EP147: What It Really Takes to Manage Diabetes with David Weingard, Founder & CEO of Fit4D
August 10, 201733:46

EP147: What It Really Takes to Manage Diabetes with David Weingard, Founder & CEO of Fit4D

Founder and CEO of Fit4D, David Weingard

David is a diabetes patient who was diagnosed with Type 1 diabetes at the age of 36 while training for a survival race. A veteran of numerous running and triathlon races (including Ironman triathlons consisting of a 2.4M swim, 112M bike and 26.2M run), David committed to rebuild his life and provide positive energy to the diabetes community while coping with the condition on a 24/7 basis. Beginning with shorter races, he gradually learned how to successfully race triathlons with diabetes and within a year, completed the famous Escape from Alcatraz Triathlon in San Francisco Bay.  He then began racing Ironman triathlons again – though this time, working through the delicate balance between insulin, food, nutrition and exercise. Through these races, David has fundraised extensively on behalf of the Juvenile diabetes Research Foundation’s (JDRF) New York City Chapter.

David’s personal experience receiving meaningful education and support from a Certified Diabetes Educator (CDE) sparked the idea for Fit4D to leverage technology to scale the patient reach of adherence and outcome improvement programs for pharmaceutical, payer and provider organizations.   In 2008, David left Microsoft to found Fit4D, building on his career as an executive in the technology sector.  

As the founder and CEO of Fit4D, David received the PM360 Elite Entrepreneur award for transforming the diabetes landscape. Under David's leadership PM360 also named Fit4D one of the top innovative healthcare startups in 2015, while ePharma named Fit4D its 2016 audience winner of the Disruptive Technology Showcase and Innovations Challenge. 

David is transforming the diabetes landscape and improving people's health in the real world every day. David was selected as the Keynote Speaker for the American Diabetes Association’s largest fundraising event, Step Out: Walk to Stop Diabetes, 2016. David has given back to the diabetes community by coaching the JDRF Ride to Cure Diabetes and the American Diabetes Association’s Tour De Cure many times, and gives back to the entrepreneur community by guiding emerging health technology founders. As a chosen finalist for the Novo Nordisk-Lyfebulb Patient Entrepreneur award, David participated in a panel on patient-centric innovation, sharing his message of hope to an international audience.  Most recently, David was the recipient of the first-ever Kate Granger Compassionate Care Award, spotlighting individual contributions to high-tech/high-touch care and awarded to those who demonstrate compassionate care in this area.


00:00 The trend with Diabetes today.
03:15 The several factors to managing Diabetes.
03:40 The economics of treating and managing Diabetes.
04:20 How the structure of care affects Diabetes management.
08:50 Critical need to engage at the local level, particularly in underserved communities.
10:00 “The only people using apps are the ones already engaged.”
14:15 The 80/20 rule applied to Diabetes patients, adherence, and cost.
15:45 Approaching Diabetes management in steps.
18:20 A guide to keeping Diabetic Populations sound.
20:20 Prescribing an App.
21:40 Best Practice Provider Extension.
24:50 Support vs. Evidence-Based Medicine.
27:30 The optimal solution for patients.
28:35 Programming & Scaling with Technology.
30:50 Standardizing Care.
33:00 You can find out more at www.fit4d.com or email info@fit4d.com

healthcare,health,marketing,diabetes,fit4d,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, 
Steven Elkins, Matthew Bunte, and Lori Smith.

Recent Episodes

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

EP529: How Stark Law, Stipends, and Noncompetes Drive Hospital Consolidation, With Eric Bricker, MD
Relentless Health ValueSeptember 16, 2026
529
39:2936.14 MB

EP529: How Stark Law, Stipends, and Noncompetes Drive Hospital Consolidation, With Eric Bricker, MD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Hey, thanks for being here with me every week, some of you every single Thursday. Give yourself a little round of applause, maybe silently and in your own head, depending on where you are. But yeah, you matter. You being here matte...

EP528: The Current State of Primary Care—Inevitable or Fixable? Will It Be Private Equity to the Rescue? With Yashaswini Singh, PhD
Relentless Health ValueSeptember 09, 2026
528
38:4935.53 MB

EP528: The Current State of Primary Care—Inevitable or Fixable? Will It Be Private Equity to the Rescue? With Yashaswini Singh, PhD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Here's the backstory for this episode. Remember episode 519 with Lisa Rosenbaum, MD, where we played a high-stakes kind of game show called "Is the Current State of Primary Care an Absolute Inevitability, or Is It a Needless, Subop...

EP526: Generic Compliance Ratios, Pass-Through Contracts, and Other Pharmacy Plumbing, With Mark Cuban and Cora Opsahl
Relentless Health ValueAugust 26, 2026
526
20:1119.06 MB

EP526: Generic Compliance Ratios, Pass-Through Contracts, and Other Pharmacy Plumbing, With Mark Cuban and Cora Opsahl

Listen on Your Favorite App Hello, all you Relentless Tribe members. If you have listened to this show for any length of time, you know one of our favorite truths around here, which is where there's mystery, there's margin. But today, we aren't just here to point out the mystery. We're here to look ...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.